Sun, Jul 14, 2024

top blank header

Nephroflash Vol-9, No-2, 2023

Nephroflash Vol-9, No-2, 2023

Overview Hemodialysis is the most common treatment for patients with end-stage renal disease (ESRD), and is required in many of these medically complex patients as a life sustaining option. Historically referred to as “renal replacement therapy”, the technique of hemodialysis has been continually refined overtime to provide better outcomes for patients. However, the rising prevalence of patients with ESRD and the limitations of current methods mandate further refinements in terms of both the device and the procedure. For instance, the limitations of currently available hemodialysis membranes include the tendency to occlude over time because of protein deposition and thrombus formation…
Overview Kidney stones are a prevalent disorder in nephrology practice, with high annual incidence reported in adults.1 In fact, one in every 11 people is expected to develop a renal stone at some point in their life.2 Although development of kidney stones may occur at any age, onset is often more common in the young and middle-aged adults; lifetime prevalence is estimated at 13% for men and 7% for women.3,4 In addition, these stones are known for their high rates of recurrence; following an initial stone event, the spontaneous five-year recurrence rate is estimated at 35% to 50%.